Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Egile Nagusiak: Xiang Tong (Egilea), Shijie Zhang (Egilea), Dongguang Wang (Egilea), Li Zhang (Egilea), Jizheng Huang (Egilea), Tianli Zhang (Egilea), Hong Fan (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...